Diasorin Sponsored Webinar: From GI Infection to Sepsis: Advancing Detection and Surveillance with LIAISON PLEX®
Includes a Live Web Event on 08/04/2026 at 11:00 AM (PDT)
Webinar Description:
Sepsis remains a leading cause of mortality, requiring rapid and accurate diagnosis to guide timely treatment. Yet, many cases originate from overlooked sources, including gastrointestinal infections that can progress to bloodstream infections. This sponsored webinar will explore how a syndromic molecular approach can close critical diagnostic gaps, enabling earlier detection of pathogens and resistance markers. Attendees will learn how the LIAISON PLEX® BSI portfolio delivers flexibility, comprehensive coverage, and actionable results to support frontline clinical decisions. In addition, we will highlight the importance of pathogen-level surveillance and data tracking tools in improving antimicrobial stewardship, infection control strategies, and hospital performance metrics.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Diasorin for this sponsored webinar.
Michelle Tabb, PhD
Chief Scientific Officer
Diasorin
Michelle Tabb, PhD, serves as Chief Scientific Officer for the molecular division of Diasorin, where she leads global scientific strategy and innovation in molecular diagnostics. With over two decades of experience in clinical microbiology, molecular genetics, and assay development, Dr. Tabb has led the design and commercialization of over 30 FDA-cleared and CE-marked diagnostic assays while serving in Focus Diagnostics, Quest Diagnostics, and ultimately within Diasorin. Her development experience includes real-time PCR-based platforms for infectious disease and oncohematology applications. She is a co-inventor on 19 U.S. patents and has extensive expertise in nucleic acid detection technologies, regulatory strategy, and translational research. Dr. Tabb leads the Scientific Affairs Department and chairs Diasorin’s Infectious Diseases Scientific Advisory Board. She provides strategic oversight for scientific publications, external collaborations, and technology evaluations. She earned her Ph.D. in the Department of Microbiology and Molecular Genetics at UC Irvine, followed by postdoctoral studies in the fields of gene expression and drug metabolism in the Department of Developmental Biology at UC Irvine.